Live
- OpenAI's GPT 5 Faces Delays Amid Data and Financial Challenges
- Sunny Leone's Name Used in Fraud Under Chhattisgarh’s Mahtari Vandan Yojana
- Gold Business Fraud Uncovered in Atmakur, Wanaparthy
- Rachakonda Police Seize Rs.88 Crore Worth Drugs, Arrest 521 Accused
- Sriram Krishnan Appointed Senior Policy Advisor for AI at the White House
- Cyclone alert at seven ports in Tamil Nadu; rain, strong winds expected
- Uttarakhand CM to attend MP govt's 'Jan Kalyan Parv' in Sagar today
- Sri Jagdamba Pearls Expands Presence with the launch of its Second Store in Bengaluru at Lulu Mall
- Congress remembers Dalits only in bad times: Mayawati taunts Rahul Gandhi on Parbhani visit
- Have time for jailed leaders but none for achievers: BJP slams Delhi govt over chess champion’s pain
Immunotherapy good for patients: Study
Immunotherapy good for patients: Study
Researchers have now shown that immunotherapy doesn't necessarily worsen complications for patients with both Covid-19 and cancer.
New York: Researchers have now shown that immunotherapy doesn't necessarily worsen complications for patients with both Covid-19 and cancer.
"Many Covid-19 complications result from an overactive immune response, leading to an increased production of proteins called cytokines," said study researcher Layne Weatherford from the University of Cincinnati (UC) in the US.
"Increased production of these proteins can cause issues like a respiratory failure. Patients with cancer are more susceptible to Covid-19 infection as well as severe complications from it," Weatherford added. According to the researchers, many patients with cancer are treated with immunotherapy, which activates the immune system against cancer to destroy it. In patients with both Covid-19 and cancer, the research team thought that immunotherapy might increase the immune system response, which could already be overactive because of the Covid-19 infection.
